UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 7, 2026
INNOVEX INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware |
| 001-13439 |
| 74-2162088 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (I.R.S. Employer Identification No.) |
19120 Kenswick Drive, Humble, Texas |
| 77338 |
(Address of principal executive offices) |
| (Zip Code) |
(346) 398-0000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
| Trading symbol(s) |
| Name of each exchange on which registered |
Common Stock, $.01 par value per share |
| INVX |
| New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ | Emerging growth company |
☐ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
Item 5.07 | Submission of Matters to a Vote of Security Holders. |
At the annual meeting of stockholders of Innovex International, Inc. (the “Company”) held on May 7, 2026, the matters voted upon and the number of votes cast for or against, as well as the number of abstentions and broker non-votes as to such matters, were as stated below (where applicable, rounded to the nearest whole share). The proposals related to each matter are described in detail in the Company’s definitive proxy statement for the annual meeting, which was filed with the Securities and Exchange Commission on March 27, 2026.
Proposal 1 Election of Directors
Each of the following nominees for directors were elected to serve a three-year term expiring at the 2029 annual meeting of stockholders by the following vote:
|
For |
|
Against |
|
Abstentions |
| Broker Non-Votes |
John Lovoi | 55,231,738 |
| 7,264,983 |
| 22,344 |
| 2,864,412 |
Angie Sedita | 58,640,091 |
| 3,855,067 |
| 23,907 |
| 2,864,412 |
Will Donnell | 61,262,832 |
| 1,237,813 |
| 18,420 |
| 2,864,412 |
Proposal 2 Ratification of Appointment of Independent Registered Public Accounting Firm
The ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the Company for the year ending December 31, 2026 was approved by the following vote:
For |
|
Against |
|
Abstentions |
|
65,317,004 |
| 42,888 |
| 23,585 |
|
Proposal 3 Advisory Vote on Executive Compensation
The advisory vote on the compensation of the Company’s named executive officers was approved by the following vote:
For |
|
Against |
|
Abstentions |
| Broker Non-Votes |
61,831,241 |
| 586,796 |
| 101,028 |
| 2,864,412 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
| Innovex International, Inc. | |
|
| |
Date: May 11, 2026 | By: | /s/ Adam Anderson |
|
| Adam Anderson |
|
| Chief Executive Officer |